| Prasugrel compared with high loading-and maintenance-dose clopidogrel in patients with planned percutaneous coronary intervention: the Prasugrel in Comparison to Clopidogrel … SD Wiviott, D Trenk, AL Frelinger, M O’Donoghue, FJ Neumann, ... Circulation 116 (25), 2923-2932, 2007 | 1128 | 2007 |
| Platelets AD Michelson, M Cattaneo, A Frelinger, P Newman Academic press, 2019 | 715 | 2019 |
| Ligands “activate” integrin αIIbβ3 (platelet GPIIb-IIIa) X Du, EF Plow, AL Frelinger III, TE O'Toole, JC Loftus, MH Ginsberg Cell 65 (3), 409-416, 1991 | 611 | 1991 |
| Circulating monocyte-platelet aggregates are an early marker of acute myocardial infarction MI Furman, MR Barnard, LA Krueger, ML Fox, EA Shilale, DM Lessard, ... Journal of the American College of Cardiology 38 (4), 1002-1006, 2001 | 541 | 2001 |
| A β3 Integrin Mutation Abolishes Ligand Binding and Alters Divalent Cation-Dependent Conformation JC Loftus, TE O'Toole, EF Plow, A Glass, AL Frelinger III, MH Ginsberg Science 249 (4971), 915-918, 1990 | 531 | 1990 |
| Dosing clopidogrel based on CYP2C19 genotype and the effect on platelet reactivity in patients with stable cardiovascular disease JL Mega, W Hochholzer, AL Frelinger, MJ Kluk, DJ Angiolillo, ... Jama 306 (20), 2221-2228, 2011 | 518 | 2011 |
| Platelet physiology T Gremmel, AL Frelinger III, AD Michelson Seminars in thrombosis and hemostasis 42 (03), 191-204, 2016 | 465 | 2016 |
| Evaluation of platelet function by flow cytometry AD Michelson, MR Barnard, LA Krueger, AL Frelinger III, MI Furman Methods 21 (3), 259-270, 2000 | 463 | 2000 |
| Monoclonal antibodies to ligand-occupied conformers of integrin alpha IIb beta 3 (glycoprotein IIb-IIIa) alter receptor affinity, specificity, and function. AL Frelinger 3rd, XP Du, EF Plow, MH Ginsberg Journal of Biological Chemistry 266 (26), 17106-17111, 1991 | 439 | 1991 |
| Selective inhibition of integrin function by antibodies specific for ligand-occupied receptor conformers. AL Frelinger 3rd, I Cohen, EF Plow, MA Smith, J Roberts, SC Lam, ... Journal of Biological Chemistry 265 (11), 6346-6352, 1990 | 400 | 1990 |
| Residual arachidonic acid–induced platelet activation via an adenosine diphosphate–dependent but cyclooxygenase-1–and cyclooxygenase-2–independent pathway: a 700-patient study … AL Frelinger III, MI Furman, MD Linden, Y Li, ML Fox, MR Barnard, ... Circulation 113 (25), 2888-2896, 2006 | 397 | 2006 |
| Occupancy of an adhesive glycoprotein receptor modulates expression of an antigenic site involved in cell adhesion. AL Frelinger, SC Lam, EF Plow, MA Smith, JC Loftus, MH Ginsberg Journal of Biological Chemistry 263 (25), 12397-12402, 1988 | 337 | 1988 |
| Pharmacodynamic assessment of platelet inhibition by prasugrel vs. clopidogrel in the TRITON-TIMI 38 trial AD Michelson, AL Frelinger III, E Braunwald, WE Downey, DJ Angiolillo, ... European heart journal 30 (14), 1753-1763, 2009 | 307 | 2009 |
| Current options in platelet function testing AD Michelson, AL Frelinger III, MI Furman The American journal of cardiology 98 (10), S4-S10, 2006 | 289 | 2006 |
| Measuring antiplatelet drug effects in the laboratory P Harrison, AL Frelinger III, MI Furman, AD Michelson Thrombosis research 120 (3), 323-336, 2007 | 267 | 2007 |
| Clopidogrel Pharmacokinetics and Pharmacodynamics Vary Widely Despite Exclusion or Control of Polymorphisms (CYP2C19, ABCB1, PON1), Noncompliance … AL Frelinger, DL Bhatt, RD Lee, DJ Mulford, J Wu, S Nudurupati, A Nigam, ... Journal of the American College of Cardiology 61 (8), 872-879, 2013 | 249 | 2013 |
| Analysis of platelet aggregation disorders based on flow cytometric analysis of membrane glycoprotein IIb-IIIa with conformation-specific monoclonal antibodies MH Ginsberg, AL Frelinger, SC Lam, J Forsyth, R McMillan, EF Plow, ... | 232 | 1990 |
| The human endogenous circadian system causes greatest platelet activation during the biological morning independent of behaviors FAJL Scheer, AD Michelson, AL Frelinger III, H Evoniuk, EE Kelly, ... PloS one 6 (9), e24549, 2011 | 229 | 2011 |
| A pharmacodynamic comparison of prasugrel vs. high-dose clopidogrel in patients with type 2 diabetes mellitus and coronary artery disease: results of the Optimizing anti … DJ Angiolillo, JJ Badimon, JF Saucedo, AL Frelinger, AD Michelson, ... European heart journal 32 (7), 838-846, 2011 | 224 | 2011 |
| Increased platelet inhibition after switching from maintenance clopidogrel to prasugrel in patients with acute coronary syndromes: results of the SWAP (SWitching Anti Platelet … DJ Angiolillo, JF Saucedo, R DeRaad, AL Frelinger, PA Gurbel, ... Journal of the American College of Cardiology 56 (13), 1017-1023, 2010 | 219 | 2010 |
